@ composer, I agree we currently have poor liquidity, however next year I do believe this could be a very different story.
Everyone is eager to see further 4C’s of the merged entity. I think these will continue to raise the profile and investor appetite for new ALC.
I do appreciate how modest Kate comes across. I have seen plenty of CEO’s over promise and under deliver. Kate has rather the opposite approach.
Kate made the admission that previous ALC had essentially no sales team (which is true, being it was only NB). Now the merged entity has a solid sales team and is continuing to recruit in sales roles, I believe we could see significant sales growth from here on out.
Other comments to make is the company is doing much better at explaining the products they offer, how the differ and the benefits to hospitals in implementing such products.
ALC Price at posting:
4.3¢ Sentiment: Buy Disclosure: Held
